
Bruce Shutan is an Employee Benefit News contributing writer based in Portland, Oregon.

Bruce Shutan is an Employee Benefit News contributing writer based in Portland, Oregon.
For reprint and licensing requests for this article, click here.
The legislation calls on Congress to lower prescription drug costs, shift subsidies directly to consumers, and enforce strict price transparency.
Employers are under pressure to keep benefits competitive while controlling costs, driving new scrutiny of PBMs, hospital prices and GLP-1 coverage for 2027.
A look at traditional PBMs and pass-through models, potential savings areas, developments and partnering with the right consultant.
Part one of this two-part series looks at the background, transparency solutions and how to understand PBM profitability.
The objective is to have a clear view of baseline vs. current Rx trend, documented savings tied to interventions and a reconciliation check on guarantees and rebates.